Phibro Animal Health (FRA:PB8) Net Change in Cash : €12.0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Phibro Animal Health Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Phibro Animal Health's Net Change in Cash for the three months ended in Mar. 2024 was €15.9 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was €12.0 Mil.

Phibro Animal Health Net Change in Cash Historical Data

The historical data trend for Phibro Animal Health's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Phibro Animal Health Net Change in Cash Chart

Phibro Animal Health Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Net Change in Cash

Get a 7-Day Free Trial

25.14

-18.85

11.51

22.74

-30.43

Phibro Animal Health Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Change in Cash	Get a 7-Day Free Trial															-29.13	3.73	1.75	-9.34	15.88

Phibro Animal Health Net Change in Cash Calculation

Phibro Animal Health's Net Change in Cash for the fiscal year that ended in Jun. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	12.285	+	-68.319	+	24.909	+	0.696
	=	-30.4

Phibro Animal Health's Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 10.495 + 1.04 + 4.466 + -0.126

= 15.9

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €12.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Phibro Animal Health Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Phibro Animal Health's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Phibro Animal Health (FRA:PB8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Phibro Animal Health Corp (FRA:PB8) » Definitions » Net Change in Cash

Comparable Companies

EOLS HROW SIGA PETQ PROC BKUH ORGO AMRX LFCR RGC ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692

Traded in Other Exchanges

PAHC:USA

Address

300 Frank W. Burr Boulevard, Suite 21, 3rd Floor, Glenpointe Centre East, Teaneck, NJ, USA, 07666-6712

Website

https://www.pahc.com

Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.

Phibro Animal Health (FRA:PB8) Headlines

No Headlines